DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndromes as Influential Pharma Players Set Foot in the MDS Landscape Las Vegas, USA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndrome as Influential Pharma Players Set Foot in the MDS Landscape ...